# Increlex Treatment of Children With Chronic Liver Disease and Short Stature

> **NCT01314508** · NA · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Growth Failure
- Chronic Liver Disease

## Interventions

- **DRUG:** Increlex

## Key facts

- **NCT ID:** NCT01314508
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-06
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor has notified us that they are not funding the study
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314508, "Increlex Treatment of Children With Chronic Liver Disease and Short Stature". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01314508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*